(Q54402573)

English

The Ability of Biomarkers to Predict Systemic Progression in Men with High-Risk Prostate Cancer Treated Surgically Is Dependent on ERG Status

scientific article published on November 9, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

The Ability of Biomarkers to Predict Systemic Progression in Men with High-Risk Prostate Cancer Treated Surgically Is Dependent on ERG Status (English)

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Hui Tang

6

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

Jan-Marie Munz

7

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

Farhad Kosari

8

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

George Vasmatzis

9

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

R. Jeffrey Karnes

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

John C. Cheville

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

Cristiane M. Ida

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

Thomas J. Sebo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

Asha A. Nair

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

language of work or name

0 references

publication date

9 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

full work available at URL

http://cancerres.aacrjournals.org/content/70/22/8994.full.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

http://cancerres.aacrjournals.org/cgi/content/abstract/70/22/8994

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21062978

23 August 2024

https://aacrjournals.org/cancerres/article-pdf/70/22/8994/2640277/8994.pdf

Portable Document Format

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

70

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

22

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

8994-9002

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

Gleason grading and prognostic factors in carcinoma of the prostate

1

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

2

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens

4

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Radical prostatectomy for high-risk prostate cancer

5

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy

6

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Identification of prognostic biomarkers for prostate cancer

7

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression

8

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

9

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

10

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

11

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

12

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

13

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma

14

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

16

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Integrative molecular concept modeling of prostate cancer progression.

17

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

18

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

ETS gene fusions in prostate cancer: from discovery to daily clinical practice

19

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables

20

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study

21

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:

22

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

23

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

HER-2 and topoisomerase II as predictors of response to chemotherapy

24

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401

25

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Low-Level TOP2A Amplification in Prostate Cancer Is Associated with HER2 Duplication, Androgen Resistance, and Decreased Survival

26

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.

28

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma

30

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.

31

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

32

1 reference

10.1158/0008-5472.CAN-10-1358

https://api.crossref.org/works/10.1158/0008-5472.CAN-10-1358

23 August 2024

Identifiers

10.1158/0008-5472.CAN-10-1358

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 May 2018

http://europepmc.org/abstract/MED/21062978

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54402573&oldid=2236489666"